Literature DB >> 31848151

PRMT1 Is Required for the Maintenance of Mature β-Cell Identity.

Hyunki Kim1, Byoung-Ha Yoon2,3, Chang-Myung Oh4, Joonyub Lee5, Kanghoon Lee5, Heein Song5, Eunha Kim6, Kijong Yi5, Mi-Young Kim7,8, Hyeongseok Kim1, Yong Kyung Kim9, Eun-Hye Seo2,3, Haejeong Heo2,3, Hee-Jin Kim10, Junguee Lee11, Jae Myoung Suh5, Seung-Hoi Koo12, Je Kyung Seong13,14, Seyun Kim6, Young Seok Ju5, Minho Shong15, Mirang Kim10,3, Hail Kim1,16.   

Abstract

Loss of functional β-cell mass is an essential feature of type 2 diabetes, and maintaining mature β-cell identity is important for preserving a functional β-cell mass. However, it is unclear how β-cells achieve and maintain their mature identity. Here we demonstrate a novel function of protein arginine methyltransferase 1 (PRMT1) in maintaining mature β-cell identity. Prmt1 knockout in fetal and adult β-cells induced diabetes, which was aggravated by high-fat diet-induced metabolic stress. Deletion of Prmt1 in adult β-cells resulted in the immediate loss of histone H4 arginine 3 asymmetric dimethylation (H4R3me2a) and the subsequent loss of β-cell identity. The expression levels of genes involved in mature β-cell function and identity were robustly downregulated as soon as Prmt1 deletion was induced in adult β-cells. Chromatin immunoprecipitation sequencing and assay for transposase-accessible chromatin sequencing analyses revealed that PRMT1-dependent H4R3me2a increases chromatin accessibility at the binding sites for CCCTC-binding factor (CTCF) and β-cell transcription factors. In addition, PRMT1-dependent open chromatin regions may show an association with the risk of diabetes in humans. Together, our results indicate that PRMT1 plays an essential role in maintaining β-cell identity by regulating chromatin accessibility.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31848151     DOI: 10.2337/db19-0685

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Epigenetics in β-cell adaptation and type 2 diabetes.

Authors:  Hyunki Kim; Rohit N Kulkarni
Journal:  Curr Opin Pharmacol       Date:  2020-11-21       Impact factor: 5.547

Review 2.  Cellular pathways influenced by protein arginine methylation: Implications for cancer.

Authors:  Jian Xu; Stéphane Richard
Journal:  Mol Cell       Date:  2021-10-06       Impact factor: 17.970

Review 3.  Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.

Authors:  Jean-Paul Bryant; John Heiss; Yeshavanth Kumar Banasavadi-Siddegowda
Journal:  Cells       Date:  2021-01-11       Impact factor: 6.600

Review 4.  Epigenetic modifications in pancreas development, diabetes, and therapeutics.

Authors:  Suneesh Kaimala; Challagandla Anil Kumar; Mohammed Z Allouh; Suraiya Anjum Ansari; Bright Starling Emerald
Journal:  Med Res Rev       Date:  2022-01-04       Impact factor: 12.388

5.  MiR-574-3p inhibits glucose toxicity-induced pancreatic β-cell dysfunction by suppressing PRMT1.

Authors:  Lixia Lv; Xiumin Wang; Jinhua Shen; Ying Cao; Qin Zhang
Journal:  Diabetol Metab Syndr       Date:  2022-07-15       Impact factor: 5.395

6.  Stabilization protects islet integrity during respirometry in the Oroboros Oxygraph-2K analyzer.

Authors:  Justin J Crowder; Ziqian Zeng; Alissa N Novak; Nathan J Alves; Amelia K Linnemann
Journal:  Islets       Date:  2022-12-31       Impact factor: 2.694

Review 7.  The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes.

Authors:  Tasnim H Beacon; Geneviève P Delcuve; Camila López; Gino Nardocci; Igor Kovalchuk; Andre J van Wijnen; James R Davie
Journal:  Clin Epigenetics       Date:  2021-07-08       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.